MedTrace Logo

Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia

NCT01150058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-05-12

No results posted yet for this study

Summary

RATIONALE: Studying cell samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer

PURPOSE: This research study is studying drug biomarkers in cell samples from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

western blotting

OTHER

flow cytometry

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Soheil Meshinchi, MD · Fred Hutchinson Cancer Center

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-11-30
Completion
2012-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01150058 on ClinicalTrials.gov